Voyager Therapeutics Inc (NASDAQ: VYGR) stock enjoyed a major increase of 10.7% on 3/19/24. The shares closed at $10.06. Moreover, trading volume in this advance was unusually high at 176% of normal. The stock has been weak relative to the market over the last nine months but has risen 11.0% during the last week.
Current PriceTarget Research Rating
With future capital returns forecasted to be in line with the cost of capital, VYGR is expected to be Value Creation neutral.
Voyager Therapeutics has a current Value Trend Rating of F (Lowest Rating). The Value Trend Rating reflects complementary signals from PTR’s two proprietary measures of a stock’s attractiveness. Voyager Therapeutics has a slightly negative Power Rating of 31 and a very low Appreciation Score of 3, leading to the Lowest Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment